Oct 8 (Reuters) - Noxopharm Ltd NOX.AX :
* NOXOPHARM LTD - ANNOUNCED TREATMENT OF FIRST PATIENT WITH ITS LEAD PIPELINE CANDIDATE, VEYONDA
* NOXOPHARM LTD - NOXCOVID-1 TRIAL WILL ENROLL UP TO APPROXIMATELY 40 PATIENTS, WITH ENROLLMENT DUE TO BE COMPLETED BEFORE END OF YEAR